Family Planning & Abortion Clinics in the US - Industry Market Research Report

Health plan: The future of the industry will be characterized by volatility

These have been tumultuous and changing times for family services clinics. Strong growth took an about-face with revenue contraction in 2020, a direct effect of COVID-19 and the ensuing economic fallout. Diminishing COVID-19 concerns and improving economic conditions brought some strong years with federal funding for Medicare and Medicaid, substantial corporate profit and per capita disposable padding funding streams. But wages remained high for clinics facing competition for skilled healthcare workers and purchase costs stayed elevated, keeping profit at COVID-19 levels. Despite the ups and downs, industry-wide revenue has been growing at a CAGR of 1.7% over the past five years and is expected to total $4.1 billion in 2023, when revenue will drop slightly by an estimated 1.0%. This industry includes freestanding centers with medical staff primarily engaged in assisting pregnant women and families in making various decisions regarding family planning. Services are provided on an outpatient basis and include contraception, genetic and prenatal counseling, voluntary sterilization and pregnancy termination. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.